Il peut aider ces cellules se reproduire, reconnatre et attaquer plus efficacement les agents pathognes trangers
2.2 GIPR agonism serves to reduce GLP-1R mediated GI AEs in the clinic Treatment with GLP-1R agonists can drive nausea, diarrhea, vomiting, and constipation, which often results in discontinuation of treatment (6-10% of patients) or reduction in dose (~15% of patients) (63)
10.1016/j.brainresbull.2023.110773 87 LiF
Timing Follow-up Marker Comprehensive metabolic panel (CMP) Why it matters Reviews kidney function, liver enzymes, electrolytes, and glucose in one broad panel
Early clinical trial results, presented at addiction medicine conferences in 2024 and 2025, have reported that participants on semaglutide experienced fewer heavy drinking days, lower craving scores on validated assessment tools, and in some cohorts spontaneous reductions in other substance use that wasnt being directly targeted
Protective role of dietary berries in cancer